Schering-Plough Merck Reverse Merger Shareholder Class Action
Schering-Plough and Merck recently announced plans to enact a reverse merger to combine both companies. Under the terms of the reverse merger, Schering-Plough shareholders would be given $10.56 in cash and .5767 shares of Merck stock for each Schering share. Although these provisions appeared to provide a percentage premium to Schering stock owners when the deal was announced, many believe that the deal has been grossly unfair to Schering-Plough stockholders. Merck stands to gain the most from the reverse-merger, and Schering-Plough stockholders were not given the benefit of meaningful negotiations with other interested parties for acquisition.
Contact Us
If you own Schering-Plough stock and you believe you have not been given full value to your investment by the Schering-Plough Merck reverse merger, and you would like to speak with an attorney about your rights, contact Seeger Weiss LLP. Our securities fraud team is investigating the Merck Schering-Plough reverse merger for a potential shareholder class action on behalf of Schering-Plough shareholders. Please use the contact form linked below, or contact us by telephone, toll free. Attorney consultations incur no obligation on your part. All initial consultations are free of charge and do not create an attorney-client relationship. Seeger Weiss LLP has office locations in New York, New Jersey, Pennsylvania, and Oklahoma and its attorneys are available to practice in courts throughout the country.
Link To Lawyer Seek's Schering-Plough Merck Reverse Merger Content:
<a href='http://www.lawyerseek.com/Practice/In-The-News-C20/Schering-Plough-Merck-Reverse-Merger-P216/'>Schering-Plough Merck Reverse Merger: Lawyer Seek</a> |
|
